Press release
Investigation announced for Long-Term Investors in CytomX Therapeutics, Inc. (NASDAQ: CTMX) shares
An investigation on behalf of current long term investors in CytomX Therapeutics, Inc. (NASDAQ: CTMX) shares.
Investors who are current long term investors in CytomX Therapeutics, Inc. (NASDAQ: CTMX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors inNASDAQ: CTMX stocks follows a lawsuit filed against CytomX Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: CTMX stocks, concerns whether certain CytomX Therapeutics, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that CytomX had downplayed issues with CX-072’s efficacy observed in the PROCLAIM-CX-072 clinical program, that CytomX had similarly downplayed issues with CX-2009’s efficacy and safety observed in the PROCLAIM-CX-2009 clinical program, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.
Those who purchased shares of CytomX Therapeutics, Inc. (NASDAQ: CTMX) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in CytomX Therapeutics, Inc. (NASDAQ: CTMX) shares here
News-ID: 2126702 • Views: …
More Releases from Shareholders Foundation
Investors in Thoughtworks Holding, Inc. (NASDAQ: TWKS) should contact the Shareh …
An investigation was announced concerning whether the takeover of Thoughtworks Holding, Inc. is unfair to NASDAQ: TWKS stockholders.
Investors who purchased shares of Thoughtworks Holding, Inc. (NASDAQ: TWKS) and currently hold any of those NASDAQ: TWKS shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors of Thoughtworks Holding, Inc. breached their…
Investigation announced for Investors who lost money with shares of Domino's Piz …
An investigation was announced for investors of Domino's Pizza, Inc. (NYSE: DPZ) shares over potential securities laws violations by Domino's Pizza, Inc.
Investors who purchased shares of Domino's Pizza, Inc. (NYSE: DPZ), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Domino's Pizza, Inc. (NYSE: DPZ)…
Investigation announced for Long-Term Investors in shares of Ocugen, Inc. (NASDA …
An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of Ocugen, Inc.
Investors who are current long term investors in Ocugen, Inc. (NASDAQ: OCGN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: OCGN stocks follows a lawsuit filed against Ocugen, Inc. over alleged…
Investigation announced for Investors who lost money with shares of Dayforce Inc …
An investigation was announced for investors of Dayforce Inc (NYSE: DAY) shares over potential securities laws violations by Dayforce Inc.
Investors who purchased shares of Dayforce Inc (NYSE: DAY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Dayforce Inc regarding its business, its prospects and its operations were materially…
More Releases for CytomX
Deadline on July 20, 2020, coming up in Lawsuit filed for Investors in shares of …
The Shareholders Foundation announced that a deadline is coming up on July 20, 2020 in the lawsuit filed for certain investors of CytomX Therapeutics, Inc. (NASDAQ: CTMX) over alleged securities laws violations by CytomX Therapeutics, Inc.
Investors who purchased shares of CytomX Therapeutics, Inc. (NASDAQ: CTMX) have certain options and there are strict and short deadlines running. Deadline: July 20, 2020. NASDAQ: CTMX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in shares of CytomX Therapeutics, Inc. (NASDAQ: CTMX …
An investor, who purchased shares of CytomX Therapeutics, Inc. (NASDAQ: CTMX), filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by CytomX Therapeutics, Inc..
Investors who purchased shares of CytomX Therapeutics, Inc. (NASDAQ: CTMX) have certain options and for certain investors are short and strict deadlines running. Deadline: July 20, 2020. NASDAQ: CTMX investors should contact the Shareholders Foundation…
Oncology Drugs Market 2019 | Industry Insight By Key Players Roche, Johnson and …
Oncology drugs and medications have become a blooming business for players in the pharmaceutical industry. Major pharmaceutical companies are focused on manufacturing and development of oncology drug. Market players have oncology drugs in pipeline, which are expected to be in the market as potential medications in near future. Also, the global oncology market is expected to gain a significant traction with the increasing prevalence of cancer. According to the National…
Global Oncology Drugs Market is Growing at a Remarkable CAGR 2018-2026 By Global …
Roche is a world leader in oncology, which is engaged in developing new approaches for advanced cancer treatment. Roche operates in two segments, which includes pharmaceuticals and diagnostics with annual sales of US$ 39.1 Bn and US$ 11.5 Bn respectively. Roche is at the forefront of cancer immunotherapy with ten investigational drug candidates currently in the clinical development phase. In 2016, the company entered into 10 new clinical collaboration agreements…
Global Oncology Drugs Market - Competitive Analysis, Growth And Revenue Analysis …
Oncology drugs and medications have become a blooming business for players in the pharmaceutical industry. Major pharmaceutical companies are focused on manufacturing and development of oncology drug. Market players have oncology drugs in pipeline, which are expected to be in the market as potential medications in near future. Also, the global oncology market is expected to gain a significant traction with the increasing prevalence of cancer. According to the National…
Global Oncology Drugs Market Analysis Report, Regional Outlook with Key Players …
Coherent Market Insights has announced the addition of the “Global Oncology Drugs Market Size Status and Forecast 2026”, The report classifies the global Oncology Drugs Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
This report studies the global Oncology Drugs Speaker market, analyzes and researches the Oncology Drugs Speaker development status and forecast in North America, Europe,…
